Scott Bartley
Psychiatry · Dallas, TXNPI 1255342143
Payments from drug & device makers
$42,731,097in general payments, 2019–2025
Across 3,191 payments — averaging $13,391 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sumitomo Pharma America, Inc.$11.4M
- Teva Pharmaceuticals USA, Inc.$7.1M
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$6.1M
- Sunovion Pharmaceuticals Inc.$3.5M
- E.r. Squibb & Sons, L.L.C.$3.3M
- AbbVie$3M
- plus $8.4M from 24 others
$224in research payments, 2019–2025
Across 1 payment — averaging $223.77 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$224
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$42,731,097 in reported general payments places this provider in the 95th percentile of 2,238 psychiatry providers in Texas.
Other psychiatry in Dallas
- Darin OkudaDallas$14.7M
- Michael DowningDallas$7.6M
- John PascoeDallas$2.3M
- Madhukar TrivediDallas$2.1M
- Manish JhaDallas$1.3M
- Mary KnesevichDallas$1.2M
- Seema GuptaDallas$1.2M
- Eric WilliamsDallas$976K
- Joel HolinerDallas$948K
- Augustus RushDallas$760K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.